Fostamatinib
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 371 publications
A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.
Journal: Leukemia & lymphoma
Published: March 30, 2026
Successful combination therapy with fostamatinib and romiplostim in refractory immune thrombocytopenia 27 years after onset
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 29, 2026
Efficacy of fostamatinib add-on for TPO receptor agonist-refractory immune thrombocytopenia
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 04, 2026
Refractory Primary Immune Thrombocytopenia With Bleeding and Thrombosis: A Case Report.
Journal: The American journal of case reports
Published: February 15, 2026
Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemic.
Journal: BMJ open
Published: February 05, 2026
A Comparative Analysis of the Efficacy, Safety and Mechanism of Action of Flebogamma DIF, Fostamatinib and Romiplostim in Immune Thrombocytopenia.
Journal: Life (Basel, Switzerland)
Published: January 08, 2026
A Clinician Perspective for a Personalized Approach to Management of Chronic Immune Thrombocytopenia with Targeted Therapies Alone or in Combination.
Journal: Journal of clinical medicine
Published: January 07, 2026
Management of autoimmune hemolytic anemia.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Translational immunothrombosis in autoimmune Heparin-Induced thrombocytopenia: targeting the FcγRIIa-Syk-BTK and complement pathways.
Journal: Clinical and experimental medicine
Published: November 05, 2025
Construction of Metastasis Prediction Models and Screening of Anti-Metastatic Drugs Based on Pan-Cancer Single-Cell EMT Features.
Journal: International journal of molecular sciences
Published: October 30, 2025
A multicentre analysis of efficacy, safety and molecular response correlates of fostamatinib in warm autoimmune haemolytic anaemia and Evans syndrome.
Journal: British journal of haematology
Published: October 28, 2025
Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.
Journal: American journal of hematology
Published: September 18, 2025
Last Updated: 04/28/2026